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Abstract
Background: Acute renal failure is a common complication of severe malaria in adults, and without renal
replacement therapy (RRT), it carries a poor prognosis. Even when RRT is available, delaying its initiation may
increase mortality. Earlier identification of patients who will need RRT may improve outcomes.
Method: Prospectively collected data from two intervention studies in adults with severe malaria were analysed
focusing on laboratory features on presentation and their association with a later requirement for RRT. In particular,
laboratory indices of acute tubular necrosis (ATN) and acute kidney injury (AKI) that are used in other settings were
examined.
Results: Data from 163 patients were available for analysis. Whether or not the patients should have received RRT
(a retrospective assessment determined by three independent reviewers) was used as the reference. Forty-three
(26.4%) patients met criteria for dialysis, but only 19 (44.2%) were able to receive this intervention due to the
limited availability of RRT. Patients with impaired renal function on admission (creatinine clearance < 60 ml/min) (n
= 84) had their laboratory indices of ATN/AKI analysed. The plasma creatinine level had the greatest area under the
ROC curve (AUC): 0.83 (95% confidence interval 0.74-0.92), significantly better than the AUCs for, urinary sodium
level, the urea to creatinine ratio (UCR), the fractional excretion of urea (FeUN) and the urinary neutrophil
gelatinase-associated lipocalcin (NGAL) level. The AUC for plasma creatinine was also greater than the AUC for
blood urea nitrogen level, the fractional excretion of sodium (FeNa), the renal failure index (RFI), the urinary
osmolality, the urine to plasma creatinine ratio (UPCR) and the creatinine clearance, although the difference for
these variables did not reach statistical significance.
Conclusions: In adult patients with severe malaria and impaired renal function on admission, none of the
evaluated laboratory indices was superior to the plasma creatinine level when used to predict a later requirement
for renal replacement therapy.
Background
Acute renal failure (ARF) is a relatively common com-
plication of falciparum malaria in adults. In patients
with severe disease the incidence of ARF may be as high
as 45% [1,2] and is associated with a mortality rate of
up to 75% [3].
The specialist care of patients with malaria-associated
ARF (MARF) in Vietnam led to a marked decline in
mortality from 75% to 26% [3]. The most important
component of this intervention was the introduction of
peritoneal dialysis, which was effective in reducing mor-
tality even when given for a relatively short duration.
Subsequently, it was shown that haemofiltration was
superior to peritoneal dialysis in MARF and was also
cost-effective, despite the greater initial outlay costs [4].
In the initial Vietnam series, 21% of patients receiving
peritoneal dialysis for MARF died, the majority within
24 hours of starting peritoneal dialysis - the authors
suggested that the earlier initiation of renal replacement
therapy (RRT), may have prevented some of these
deaths [3].
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necrosis (ATN) associated with localization of host
monocytes in the kidney as well as sequestration of
parasitized red blood cells in the microcirculation [5],
although the precise mechanism of renal injury is not
known. Patients who have ATN will usually require
early RRT, however on admission to the hospital it is
difficult to distinguish patients with ATN from patients
with reversible pre-renal causes that will respond, albeit
at different rates, to simple rehydration and effective
anti-malarial treatment [6].
At present, the decision to initiate RRT is usually
based on the clinical assessment of treating physicians.
I ti sg e n e r a l l yg u i d e db yap a t i e n t ’sr e s p o n s et ot h e r a p y
during the early stages of their admission, and is often
influenced by the limited availability of trained staff,
available facilities and economic factors. Therefore, the
initiation of RRT is often delayed until the patients have
failed to respond to rehydration and anti-malarial che-
motherapy. This may be too late [3].
Even in resource-rich settings the differentiation of
reversible pre-renal ARF from established ATN is
challenging at initial presentation. This is because of a
lack of uniform diagnostic criteria for ATN. Definitive
morphological diagnosis with biopsy is rarely justified
and improvement in renal function following fluid
repletion is a retrospective inference. Therefore, sev-
eral laboratory tests have been devised that might help
differentiate these populations. They are based on
assessment of the renal response to reduced perfusion,
which is the avid retention of salt and water in an
attempt to preserve the circulating volume. Proposed
tests include: the renal failure index (RFI), the frac-
tional excretion of sodium (FeNa), the fractional
excretion of urea (FeUN), the urea to creatinine ratio
(UCR), the urine to plasma creatinine ratio (UPCR),
and the urinary sodium (UNa) and osmolality (UOsm)
[7-11] (Table 1). However such tests are not uniformly
accepted [12] and they have not been assessed system-
atically in the prediction of the requirement for RRT
[13].
More recently several biomarkers of acute kidney
injury have been described. The most promising of
these is neutrophil gelatinase-associated lipocalcin
(NGAL), which is secreted into the urine from the
ascending loop of Henle and collecting ducts of the kid-
ney in proportion to the degree of acute injury [14].
Urinary NGAL on admission is correlated with mortality
and a later requirement for RRT in critically ill patients
[15].
The aim of this study was to assess the ability of these
tests of ATN/AKI to predict the later requirement for
RRT in patients with severe falciparum malaria. Diag-
nostic tests that facilitate initiation of RRT might poten-
tially improve outcome.
Methods
The study was conducted at Chittagong Medical College
Hospital, Bangladesh, a large tertiary referral hospital in
the country’s second largest city. The hospital serves a
wide area in which malaria is endemic with peaks in
transmission during the wet season. Transmission inten-
sity is low and severe malaria is predominantly seen in
adults.
Patients enrolled in clinical trials of adjuvant therapy
of severe malaria between 2003 and 2007 were included
in this study. From 2003 to 2005 patients were enrolled
in a trial assessing N-acetylcysteine (NAC) [16]. In 2006
and 2007 the patients were drawn from those assessed
f o rat r i a le x a m i n i n gt h ee f f i c a c yo fl e v a m i s o l e( s t u d y
ongoing). Informed consent was obtained from the
families of all patients enrolled in the trials. All studies
Table 1 Laboratory tests used to differentiate pre-renal ARF from ATN [7-11]
Test Formula used to calculate
Renal failure index (RFI) (Urine sodium × plasma creatinine)
Urinary creatinine
Fractional excretion of sodium (FeNa) (Urine sodium/plasma sodium) × 100
(Urine creatinine/plasma creatinine)
Fractional excretion of urea (FeUN) (Urine urea/plasma urea) × 100
(Urine creatinine/plasma creatinine)
Plasma urea to creatinine ratio (UCR) plasma urea/plasma creatinine
Urinary to plasma creatinine ratio (UPCR) urinary creatinine/plasma creatinine
Urinary sodium concentration (UNa) n/a
Urinary osmolality (UOsm) n/a
RFI: > 1, evidence for ATN, FeNa: <1% evidence for pre-renal disease, >2% evidence for ATN, FeUN: <35% evidence for pre-renal disease, >50% evidence for ATN,
UCR: >20 evidence for pre-renal disease,<15 evidence for ATN (n.b. non SI units), UPCR: >40 evidence of pre-renal disease, <20 evidence for ATN, UNa: <20
mmol/L evidence for pre-renal disease, >40 mmol/L evidence for ATN, UOsm: >500 mosm/kg evidence for pre-renal disease, <450 mosm/kg evidence for ATN.n /
a: not applicable.
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Page 2 of 9had been approved by the ethics committee of the Min-
istry of Health, Bangladesh and OXTREC, the ethics
committee for studies in tropical countries of Oxford
University, UK.
All patients had to satisfy pre-specified criteria for
severe malaria (Table 2) and have asexual forms of P.
falciparum on a blood film.
Blood and urine were collected on study enrolment.
These values were used to determine the laboratory
indices. Malarial thick and thin films were read immedi-
ately and basic laboratory results (Plasma sodium,
plasma potassium, blood urea nitrogen, blood glucose,
plasma bicarbonate, plasma pH, haemoglobin, haemato-
crit) were available within minutes through the use of a
portable hand held analyser (iStat with EC8+ cartridges,
Abbott, Illinois, USA). Plasma and urine specimens were
frozen at -80°C for subsequent biochemical analysis in
Bangkok, Thailand. The urine NGAL was measured
using a commercial ELISA (R&D Systems, Abingdon,
UK) in Amsterdam.
The patients were managed according to the published
WHO guidelines [17,18] and were resuscitated with nor-
mal saline, titrated against the clinical assessment of
dehydration. Apart from the simple investigations avail-
able on admission (above), which were repeated when
clinically indicated, none of the measures of ATN/AKI
were available to the treating clinicians. There were two
haemodialysis machines in the hospital; if these were
unavailable peritoneal dialysis was provided where
supervising staff and facilities were available.
A premorbid plasma creatinine was not available in
any of the patients due to their remote location in a
resource-poor setting. The usual classification of a fifty
percent increase in the plasma creatinine could thus not
be used to define acute renal failure. Accordingly acute
kidney injury was defined as a creatinine clearance less
than 60 milliltres per minute, a figure commonly used
to define clinically significant renal dysfunction [19,20].
Creatinine clearance was estimated using the Cockcroft
and Gault formula [21]. The case records were retro-
spectively reviewed by two independent internal medi-
cine physicians (JH and PC) to determine whether
patients should have received treatment with dialysis
according to pre-defined criteria (Table 3). If there was
disagreement, the chart was reviewed by an intensive
care physician (AMD) and a consensus was reached
The results from the de-identified data were recorded
in a computerised database (Microsoft Access, Microsoft
Corporation, USA) and then analysed using statistical
software (Stata 9.0, Statacorp, Texas, USA). The perfor-
mance of the tests was assessed using receiver operating
characteristic (ROC) curves. Dichotomous variables
were analysed using the Chi squared, Fisher’s exact and
Kruskal-Wallis tests.
Results
Patients
Of the 184 patients assessed for these studies, 163 had
sufficient data for analysis. Eighty four (51.5%) patients
had a calculated creatinine clearance < 60 ml/min at
study enrolment (Figure 1). Baseline characteristics of
the patients are shown in Table 4.
The patients were very unwell: 90% had a CAM score
≥2 [22] and sixty six patients (40.5%) died. Renal impair-
ment was more common in older patients, those with a
higher peripheral parasitaemia, a higher CAM score and
an elevated plasma bilirubin. Predictably these patients
were more likely to have a lactic acidosis and elevated
plasma potassium.
There was 87% agreement between the internal medi-
cine physicians in defining the patients with an indication
for RRT. After discussion with the intensive care physi-
cian, there was unanimous consensus on the forty-three
patients (26.4%) who should have received RRT. Twenty-
four of these patients were unable to receive it for logistic
reasons. Of the 19 patients who received RRT, seven
Table 2 Criteria for severe malaria (after Hien et al)[1]
On admission:
1. Cerebral malaria. GCS < 11.
2. Shock. Systolic blood pressure <80 mmHg, with cool extremities
3. Severe anaemia. Haematocrit <20%, with parasite count > 100,000/
μl
4. Liver disease. Total bilirubin > 42 μmol/L with parasite count >
100,000/μl
5. Hyperparasitaemia. Peripheral parasite count >10%
6. Acidosis. Venous bicarbonate <15 mmol/L
On admission, or developing within the first 72 hours:
7. Hypoglycaemia. Blood glucose <2.2 mmol/L
8. Convulsions
9. Pulmonary oedema
10. Renal failure. Plasma creatinine > 265 μmol/L
Table 3 Criteria used by reviewers to determine the
requirement for dialysis (one or more required)
1. Evolving hyperkalaemia (K greater than 5.5 mmol/L) and renal
impairment.*
2. Evolving acidosis (pH < 7.35, HCO3 < 15) and renal impairment.*
3. Fluid overload not manageable by conservative measures and
evolving renal impairment. *
4. Uncontrolled seizures in the setting of renal impairment*
5. Pericarditis in the setting of renal impairment*
6. Dialysis initiated appropriately by treating physicians before above
criteria were met (eg. significantly worsening renal impairment
despite conservative measures)
* Renal impairment: BUN greater than 30 mmol/L or plasma creatinine > 200
μmol/L.
Hanson et al. Malaria Journal 2011, 10:217
http://www.malariajournal.com/content/10/1/217
Page 3 of 9patients (37%) died - a figure similar to the mortality rate
in the series of patients without renal impairment (34%).
However, in the 24 patients meeting criteria for RRT but
who were unable to receive it, there were eighteen deaths
(75%) - a statistically significant difference (p = 0.01). Two
of the patients who received RRT had haemodialysis, the
others received peritoneal dialysis. The majority of patients
received RRT in the first 48 hours of admission (Figure 2).
The duration of required RRT was relatively brief: surviv-
ing patients had dialysis for a median of three days (range
2-6 days). The most frequent indication for RRT was
metabolic acidosis (Table 5)
The data from patients with a creatinine clearance <
60 ml/min on admission (n = 84) were analysed to
determine whether laboratory indices for ATN/AKI
could predict a later requirement for RRT (Tables 6 and
7, and Figures 3a, 3b, 3c, 3d and 4). Measurement of
the plasma creatinine on admission had the greatest
ability to define a later requirement for RRT as deter-
mined by the area under the receiving operator charac-
teristic curve (AUROC): 0.83 (95% confidence interval
(CI) 0.74-0.92). If only the patients who actually received
RRT were analysed admission plasma creatinine had a
greater AUROC (0.69 (95% CI 0.55-0.83) than all
laboratory indices except urinary osmolality (0.74 (95%
CI 0.6-0.87), p = 0.37 for a difference).
Discussion
In this series of 163 patients the incidence of death and
renal impairment was similart oal a r g em u l t i n a t i o n a l
series of adults suffering from severe malaria [1]. It is
likely then that it was a representative sample of adult
patients suffering from MARF in a resource poor area
of unstable malaria transmission.
In patients with renal impairment on admission, none
of the evaluated parameters was superior to the simple
measurement of plasma creatinine measurement in pre-
dicting a later requirement for RRT. Plasma creatinine
has the additional advantage of being widely used and
understood by clinicians and of being relatively inexpen-
sive. It requires no mathematical derivation and has
additional established uses including the adjustment of
drug dosages. The other laboratory tests of ATN/AKI
assessed in this study often require additional specimen
collection, mathematical calculation and invariably entail
additional costs. They do not appear to improve signifi-
cantly the ability of clinicians to predict a later require-
ment for RRT. In busy, resource-poor settings they are
thus tests of poor discriminatory value.
The series confirms that prompt RRT in the manage-
ment of MARF reduces mortality. In the 19 (58%)
patients who had an indication for RRT and who were
able to receive this intervention, the mortality rate was
37%: significantly lower than the mortality rate in those
who were unable to receive RRT (75%, p = 0.01) and no
higher than the rate seen in patients in the series with-
o u tA R F .T h i si sd e s p i t et h ef a c tt h a to n l yt w oo ft h e
patients were able to receive the more effective haemo-
dialysis [4]. As in previous studies the duration of
required peritoneal dialysis was relatively brief [3].
Figure 1 Overview of the patients.
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Page 4 of 9Table 4 Baseline patient characteristics classified by admission creatinine clearance
Variable All patients n = 163 CrCl > 60 ml/min n = 79 CrCl < 60 ml/min n = 84 P
Age (years) 35 (23 - 45) 30 (23 - 40) 37 (23 - 50) 0.02
Male sex 136/163 (80%) 66/79 (84%) 64/84 (76%) 0.33^
Parasite count % (peripheral) 2.7 (0.9 - 9.5) 1.9 (0.7 -4.9) 3.6 (1.1 - 11.3) 0.003
Glasgow Coma Score 8 (7 - 9) 8 (6 - 10) 9 (5 - 11) 0.8
Mean arterial pressure (mmHg) 80 (73 - 90) 81 (73 - 93) 80 (70 - 87) 0.2
Heart rate (beats per minute) 113 (102 - 131) 112 (94 - 131) 114 (103 - 134) 0.54
Respiratory rate (breaths per minute) 30 (26 - 36) 30 (25 - 36) 30 (26 - 36) 0.53
Oxygen saturation (%) 96 (94- 97) 96 (94 - 98) 96 (93 - 97) 0.61
Glucose (mmol/L) 6.8 (5.3 - 10.1) 7.2 (5.7 - 7.2) 6.3 (4.9 - 9) 0.09
Sodium (mmol/L) 133 (128 - 137) 132 (128 - 137) 133(129 - 139) 0.28
Potassium (mmol/L) 4.3 (3.8 - 4.8) 4.2 (3.7 - 4.6) 4.5 (3.8 - 4.9) 0.03
Bicarbonate (mmol/L) 16.9 (15 - 17.5) 19.3 (16 - 21.3) 14 (12 - 17.1) 0.0001
Base excess -8 (-12 - -3) -5 (-8 - -2) -11 (-16 - -7) 0.0001
Lactate 4.7 (3.3-7.2) 4.3 (3.1 -5.5) 5.6 (3.7 -10.1) 0.002
Blood urea nitrogen (mmol/L) 14.7 (9 -26) 9.2 (6.4 - 12.1) 24.9 (18 - 34.3) 0.0001
Plasma creatinine (μmol/L) 122 (79.6 - 202) 79.2 (61.6 - 97.2) 202 (142 - 316) 0.0001
Haematocrit (%) 29 (23 - 35) 32 (26 - 36) 29 (23 - 35) 0.06
Urinary sodium (mmol/L) 44 (30 - 66) 48 (30 - 79) 40 (30 - 63) 0.35
FeNa 0.71 (0.28 - 1.37) 0.39 (0.2 - 0.84) 1.05 (0.52 - 2.11) 0.0001
RFI 0.95 (0.4 - 1.8) 0.5 (0.2 - 1.1) 1.3 (0.7 - 2.8) 0.0001
UOsm (mosm/L) 498 (391 - 674) 614 (503 - 725) 412 (357 - 518) 0.0001
FeUN 46 (29 - 65) 51 (38 - 66) 37 (24 - 64.5) 0.001
UPCR 53 (29.9 - 85.1) 80.5(60.3 - 115.8) 32.6 (19 - 46.9) 0.0001
Urea:creatine ratio 29.4 (21.8 - 37.8) 28.7 (20 - 38.4) 29.4 (22.4 - 37) 0.86
Plasma bilirubin (total) (μmol/L) 72 (35.9 - 160) 61.1 (29.9 - 111.3) 94.7(43.3 - 204.9) 0.01
Plasma bilirubin (direct) (μmol/L) 28.6 (12 - 77) 18.6 (10.4 - 42.8) 44 (18.8 - 113.3) 0.0001
NGAL 322 (226 - 586) 232 (171 - 333) 468 (304 - 733) 0.0001
All numbers, except male sex, are medians (interquartile range)
All P values comparing the populations with CrCl > 60 ml/min and CrCl < 60 ml/min are determined using Kruskal-Wallis, except ^ Fisher’s exact.
CrCl: creatinine clearance, FeNa: Fractional Excretion of sodium, RFI: Renal Failure Index, UOsm: Urinary osmolality. FeUN: Fractional excretion of urea nitrogen,
UPCR: urine:plasma creatinine ratio, UCR: plasma urea:creatinine ratio (n.b. non SI units), NGAL: neutrophil gelatinase-associated lipocalcin.
Figure 2 Day of hospital admission that dialysis was commenced.
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died had a significant delay in starting dialysis: receiving
it 24 hours after an indication was met.
Patients were unable to receive RRT for a range of
reasons; all the consequence of limited resources: dialy-
sis equipment was periodically unavailable (for financial
or logistical reasons), intermittently there was a shortage
of skilled staff to assess patients and administer and
supervise dialysis and, occasionally, there was limited
access to diagnostic facilities to assess the indications
for dialysis. Such phenomena are not unusual in regions
where patients with MARF will be managed.
Although almost half of the patients in the studies
presented to hospital with a CrCl < 60 ml/min, only
46% of these would later require RRT, demonstrating
that the majority of patients with malaria presenting
with renal impairment will respond to anti-malarial che-
motherapy and fluid repletion alone. As in previous
studies, patients with renal impairment were morel
likely to demonstrate evidence of hepatic dysfunction
[3]. Only 22/43 patients who had an indication for dialy-
sis had their urine output recorded, however, no more
than 8 of these were oliguric. This reinforces the obser-
vations made by other investigators that MARF may be
non-oliguric [3] and it underlines the unreliability of
this clinical feature in identifying patients who may
Table 6 Receiver Operating Characteristic (ROC) analysis of the ability of various laboratory tests performed on
admission to predict the later requirement for RRT in patients with an admission creatinine clearance of less than 60
ml/minute
Index Median values in patients who should have received dialysis Patients who
were able to
have dialysis
Patients who
should have had
dialysis
p*
AUC 95% CI AUC 95% CI
Plasma creatinine (μmol/L) 290(226 - 379) 0.69 (0.55-0.83) 0.83 (0.74 - 0.92)
Creatinine clearance (ml/min) 24.7 (20.7 - 31) 0.66 (0.51-0.81) 0.78 (0.68 - 0.88) 0.1
RFI 2.5 (1.5 - 3.6) 0.64 (0.48-0.8) 0.75 (0.64 - 0.86) 0. 21
FeNa 1.89 (1.1 - 2.66) 0.64 (0.48-0.79) 0.75 (0.64-0.86) 0.21
Blood urea nitrogen (mmol/L) 32.5 (27.8 - 36.1) 0.66 (0.51-0.81) 0.77 (0.66 - 0.87) 0.18
UOsm (mosm/L) 382 (347 - 421) 0.74 (0.6 - 0.87) 0.71 (0.59 - 0.82) 0.1
UPCR 21.3 (17.8 - 29.5) 0.64 (0.49 - 0.78) 0.75 (0.65 - 0.86) 0.23
Urinary sodium (mmol/L) 51 (39 - 56) 0.61 (0.45 - 0.76) 0.65 (0.53 - 0.77) 0.02
UCR 28.6 (23.1 - 31.9) 0.56 (0.41 - 0.72) 0.60 (0.48 -0.72) 0.0001
FUN 36 (21 - 41) 0.37 (0.21 - 0.53) 0.41 (0.28 - 0.54) <0.0001
Plasma bicarbonate (mmol/L) 13 (11.8 - 13.6) 0.64 (0.52 - 0.77) 0.70 (0.59 - 0.82) 0.09
Plasma potassium (mmol/L) 4.7 (4.4 - 5.1) 0.44 (0.26 - 0.61) 0.65 (0.54 - 0.77) 0.02
Urine NGAL (ng/ml) 644 (445 - 780) 0.62 (0.44 - 0.79) 0.68 (0.55 - 0.80) 0.045
* comparison of AUC in patients who should have had dialysis with plasma creatinine, using chi squared.
Table 7 Sensitivity, specificity, and the positive and
negative predictive values of various selected laboratory
tests performed on admission to predict the later
requirement for dialysis^: optimal cut-offs in this series
Index Optimal cut
off**
Sensitivity Specificity PPV NPV
Plasma creatinine
μmol/L
202 77 78 75 80
RFI 1.4 71 72 69 74
FeNa 1.88 50 91 83 67
Urine Osmolality
mosm/L
419 63 56 56 63
UPCR 43 84 44 57 76
Urinary Sodium
mmol/L
34 90 44 59 83
Bicarbonate 15 82 56 62 78
NGAL 510 65 70 65 70
AUC: Area under receiver operating characteristic curve, RFI: Renal failure
index, FeNa: Fractional excretion of sodium, UPCR: Urine: plasma creatinine
ratio, FUN: Fractional excretion urea. NGAL: neutrophil gelatinase-associated
lipocalcin.
** Determined using the ROC curve
^ Patients who should have had dialysis.
Table 5 Indication for renal replacement therapy
Indication Number
Renal impairment and acidosis 28
Renal impairment, acidosis and hyperkalaemia 8
Worsening renal impairment despite conservative measures 4
Worsening renal impairment and convulsions 1
Renal impairment and hyperkalaemia 2
Pericarditis 0
Convulsions 0
Total 43
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Page 6 of 9require RRT. This, together with the difficulty in obtain-
ing reliable 24 hour collections and the obligatory delay,
calls into question the utility of the WHO definition of
malarial acute renal failure as “ap l a s m ac r e a t i n i n ec o n -
centration >265 μmol/L with 24 h urine output of <400
ml” [2].
In a recent meta-analysis of critically ill patients the
measurement of NGAL had an AURROC of 0.78 (95%
CI 0.65-0.92) when predicting a requirement for RRT
[15]. The performance of urinary NGAL in this series
was similar (0.68 (95% CI 0.55-0.80) and was strongly
correlated with plasma creatinine (p < 0.0001, rs = 0.64).
However, while the optimal cut-off and timing of speci-
men collection in different patient groups with AKI has
yet to be established [14,15,23], at this stage the knowl-
edge of a urinary NGAL does not appear to significantly
improve the ability of the clinician to predict a require-
ment for RRT in this population.
Plasma UCR appears to have a limited role in asses-
sing the volume state of patients with severe malaria.
Elevated BUN concentrations, reflecting the hypercata-
bolic state associated with severe malaria [24], lead to
numerically greater UCRs. This finding may also have
affected the performance of the FeUN test. We had
anticipated that the elevated plasma urea would be cor-
rected for by analysis of the fractional excretion of urea
because in ATN impaired passive reabsorption of urea
(a) (b)
(c) (d)
Figure 3 Receiver operating characteristic curve showing the ability of variables to predict a later requirement for dialysis in those
patients who should have received dialysis. 3a) Plasma creatinine 3b) Fractional excretion of sodium 3c) Urinary neutrophil gelatinase-
associated lipocalcin 3d) Plasma bicarbonate.
Figure 4 Proportion who should have received RRT by
admission serum creatinine.
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However in our series we found that the FeUN in
patients who would later require dialysis was actually
significantly lower. A suggested mechanism is that in
hypercatabolic states the osmotic effect of higher tubular
concentration of urea complicates the calculation of
FeUN [7]. Indeed, more than 60% of the patients in the
analysis had a urine urea:creatinine ratio greater than
10, the usual upper range of normal for this value.
There were several deficiencies in the study. A retro-
spective definition of whether a patient should have
received RRT was the primary reference for analysis.
Patients were classified from case files that were not
prepared prospectively to collect these data which were
sometimes incomplete. However the files were reviewed
independently by three experienced clinicians and after
discussion, there was unanimous consensus. The fact
that over 90% of patients met criteria for RRT in the
first 72 hours of their admission suggests that RRT ther-
apy was required for MARF rather than a complication
of inpatient management. Indeed when the four patients
who met criteria for RRT after 72 hours of admission
were removed from the analysis, the performance of all
the laboratory indices was almost identical. A require-
ment for RRT was also no different in the patients
enrolled in each of the two trials arguing against a con-
founding effect of NAC or levamisole. Although there
are data supporting the efficacy of NAC in preventing
radiocontrast nephropathy [25], there are no data sug-
gesting a benefit of NAC in critical illness nephropathy
[26,27]. Levamisole is not known to have any major
effect on renal function [28]. Specimens were collected
on admission before the administration of NAC or leva-
misole precluding the possible influence of either agent
on any of the laboratory indices.
By classifying renal impairment as a plasma creati-
nine greater than 200 μmol/L in our criteria for dialy-
sis, we biased our analysis in favour of plasma
creatinine defining the dialysis population. However,
plasma creatinine performed significantly better than
BUN (another measure of renal function) and plasma
bicarbonate - the criterion that actually qualified the
patient for dialysis in 85% of the cases. Plasma creati-
nine is also used to define FeNa, FUN, RFI and UPCR,
yet despite these indices measuring a second parameter
of tubular function they performed no better than
plasma creatinine alone. The plasma creatinine was
not available to the clinicians managing the patients
during their admissions and thus was not used to
define the 19 patients who received RRT. If analysis is
restricted to the patients who actually received RRT,
plasma creatinine still has a greater AUROC than all
other indices except urinary osmolality and the differ-
ence between these two variables is not significant.
Although the figure of 200 μmol/L was very similar to
the optimal cut-off for dialysis in this series of 202
μmol/L, the figure of 200 μmol/L was defined before
the analysis. Acidosis and convulsions are also mani-
festations of severe malaria without renal impairment,
hence using them as criteria to define the patients who
“should have had RRT” is potentially flawed. However,
as noted above, plasma creatinine was superior to
plasma bicarbonate as a predictor of RRT, only one
patient was dialysed because of convulsions, and this
was in the setting of declining renal function.
There were no scales available for weighing obtunded
patients thus bedside estimations of weights were used
to derive the creatinine clearance (CrCl). Although these
measures are clinically realistic, they introduce a poten-
tial error into the calculation. Furthermore, formulae
used to estimate creatinine clearances are designed for
use in patients with chronic renal impairment and our
series composed of ethnic Bangladeshis in whom the
Cockcroft and Gault formula has not been formally vali-
dated. However, we felt that it was best to use a
mechanism that would control to some degree for the
range of body types that were included in the series.
Comparisons between the young muscular men and
older women in the series may have been equally defi-
cient if using the plasma creatinine as the reference for
glomerular filtration rate.
For a new diagnostic test to be implemented it should
be more sensitive than the existing diagnostic methods
and it should not be more costly, less safe or less speci-
fic [29]. The measurement of plasma creatinine on
admission in patients with severe malaria is safe and
relatively inexpensive. In this series of patients it was
able to predict the later requirement for RRT as accu-
rately as the more complicated and expensive tests used
to diagnose ATN/AKI. From these data there appears
little to recommend the use of these tests in the
resource poor settings where most patients with severe
malaria will be managed.
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